Pulse Fibre harnesses Adtran for multigigabit network expansion in UK home developments
Adtrantoday announced that Pulse Fibre has selected its 10Gbit/s XGS-PON fiber access platform to enable the next phase of its network expansion. Specializing in new housing developments, Pulse Fibre will be delivering Gigabit and multigigabit services with symmetrical speeds up to 10Gbit/s to more than 250,000 homes in both rural and urban areas. The new network enables Pulse Fibre to provide property developers with early-stage connectivity for essential systems, such as EV chargers and security networks. The strategic deployment leverages Adtran’s scalable broadband technology to ensure a flexible, future-proof network ready to adapt to evolving subscriber demands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241014717629/en/
Adtran’s technology is helping Pulse Fibre deliver ultra-fast connectivity to new housing developments across the UK. (Photo: Business Wire)
“This collaboration with Adtran is a key step in our mission to deliver fast, reliable broadband to new housing developments across the UK. With Adtran’s compact, energy-efficient technology, we’re enabling connectivity during the building process through our Construction Mode, allowing developers to seamlessly integrate smart infrastructure,” said Robert Buckingham, operations director at Pulse Fibre. “For residents, we provide day one connectivity, supporting work-from-home and smart home needs, while also aligning with our sustainability goals to minimize environmental impact and build a greener, more resource-efficient future.”
Pulse Fibre’s new solution is bringing high-speed connectivity to a growing number of households across the UK. It features Adtran’s high-performance optical network terminals (ONTs) and its software-defined optical line terminals (OLTs), underpinned by the Mosaic Cloud Platform (Mosaic CP). Adtran’s SDX 6320 OLT makes it simple for Pulse Fibre to expand its services across diverse environments, from rural villages to dense urban centers, all while maintaining a focus on energy efficiency and sustainability. Mosaic CP adds a layer of intelligence, providing flexible, programmable network management that accelerates service activation, reduces operational complexity and maximizes profitability by shortening revenue cycles.
“We’re excited to see our technology propelling Pulse Fibre’s growth. Designed for rapid deployment and comprehensive network management, our solutions are empowering Pulse Fibre to bring fast, reliable internet to a broader base of subscribers,” commented Stuart Broome, GM of EMEA sales at Adtran. “It’s all about providing a network that meets today’s demand for high-speed streaming and gaming while staying ahead of the curve and ensuring future readiness. Our technology will enhance the digital experience for Pulse Fibre’s customers while also supporting economic growth and innovation in the communities they serve.”
Watch this video for more information on how Adtran is helping Pulse Fibre rapidly scale its network.
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
About Pulse Fibre
Pulse Fibre is building the next generation of full fibre infrastructure for the UK, deploying state-of-the-art future-proof FTTP connectivity. We implement our own dedicated fibre optic network, giving us full control of design, installation and maintenance. Our mission is to level the playing field among Internet Service Providers and Fibre Network Operators; ultimately empower individuals and organisations with the power of affordable high-speed internet, enabling them to thrive and stay connected in an increasingly digital world. We deliver network speeds up to 10Gb/s for both upload and download. This is vital for those who rely on a high-speed network in both directions for home-working, business, collaboration tools and other evolving internet usage. From the national fibre network to the WiFi in the home, our infrastructure is focused on the latest, high-capacity, next-generation technology. So, when you invest in Pulse Fibre, you know that your properties will have connectivity that is future-proofed.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241014717629/en/
Contacts
For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.com
For investors
Rhonda Lambert
+1 256 963 7450
investor.relations@adtran.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 22:46:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 22:35:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 21:32:00 EET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 14:00:00 EET | Press release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 14:00:00 EET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom